AI Terminal
Primary Health Properties PLC
Earnings Release • Mar 16, 2020
4780_rns_2020-03-16_5b9d2e67-490d-4b68-81b5-41a82bc56c1c.html
Earnings Release
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
Hardman & Co Research
Hardman & Co Research: Q&A with Mike Foster on Primary Health Properties (PHP): Final results show accelerating rental growth
16-March-2020 / 13:10 GMT/BST
Hardman & Co Research: Final results show accelerating rental growth
Primary Health Properties (PHP) is the topic of conversation when Mike Foster, Analyst at Hardman & Co joins DirectorsTalk. We discuss the importance of Ireland and MedicX, the effect of the current global health crisis, dividends, raised estimates for dividend growth and Mike provides a summary of the risks to investors.
Please click on the link below to listen to the interview:
If you are interested in meeting the company, you can register your interest by clicking on the above link
| To contact us: Hardman & Co 35 New Broad Street London EC2M 1NH www.hardmanandco.com Follow us on Twitter @HardmanandCo |
Contact: Mike Foster +44 20 7194 7633 |
[email protected] |
Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement.
About Hardman & Co: For the past 25 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge. Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services. Some of our notes have been commissioned by the company which is the subject of the note; this is clearly stated in the disclaimer where this is the case.
Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259.
Our research is provided for the use of the professional investment community, market counterparties and sophisticated and high net worth investors as defined in the rules of the regulatory bodies. It is not intended to be made available to unsophisticated retail investors. Anyone who is unsure of their categorisation should consult their professional advisors. This research is neither an offer, nor a solicitation, to buy or sell any security. Please read the note for the full disclaimer.
Dissemination of a CORPORATE NEWS, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.
End of Announcement - EQS News Service
998147 16-March-2020